Loading viewer...
investor_presentation
Format: PDF investor_presentation
This presentation outlines Mesoblast's capital raising strategy, including an accelerated entitlement offer and institutional placement for new shares.
FDA Clears Ryoncil IND for Registration Trial in DMD
presentation
investor_presentation
29 Pages
Truist Financial Corporation
investor_presentation
MEDNAX